We illustrate and sell minimalistic art posters of iconic places, buildings, nature scenes and architecture in Norway. Our primary market is B2C through our website wallstories.no, but we also do custom illustrations for hotels, offices and other industries in the B2B market. In addition we run a gallery and showroom, Too Many Prints in Oslo, and the website toomanyprints.com.

Flow Insights is a data, insights, and analytics partner for physical retail. We work with some of the most recognized brands and retailers in the world. Clients use us to make faster and more accurate assortment and space decisions to improve shoppability, reduce waste, simplify operations, and increase profitability.

Norwegian holding company is driven by youth. Ellingsen Technologies & Ellingsen Partners. Ellingsen Group is a company that aims to create a platform for creators and artists. We believe in art, therefore we want to create a stable income for creators with our two main projects. These two projects are Properfans and Bitful.

Batteries - Made in Norway Concept, design, prototype, production, repairs. ​ Batteries for golf carts, forklifts, e-bikes, small EVs, wheelchairs and more — giving your eVehicles a second life! Battkomp designs produce, and repairs li-ion batteries in the 0.5 to 10 kWh range for mobility applications. Battkomp can produce batteries in any shape or size, complete with housing, safety systems, appropriate connectors, and communication systems to ensure complete compatibility with the host device.​​ 1. Help your product development by providing custom batteries for prototypes 2. Give older battery-driven products a new life by converting from lead acid or NiMH to lithium 3. Provide replacement batteries for products where the OEM is no longer available ​ The battery production services are targeted toward customers who wish to order at least 5-10 batteries.

Tipio en markedsplass for gruppekjøp som gir forbrukere de beste dealene på kjente produkter og tjenester. Vi endrer markedsdynamikken som kun er drevet av push, hvor forbrukerne endelig kan være med å påvirke og engasjere seg i en toveis dialog med marked. På den andre siden taper bedrifter over 80 milliarder dollar bare i år på de strenge reglene for GPDR/personvern og at ca 50% skrur av all sporings muligheter. Bransjen er i en enorm omstilling og er desperate etter alternative løsninger som hjelper de med dette. Det er her Tipio kommer inn å bidrar med økt salg, senke risikoen knyttet til markedsføring og tilbyr unike datainnsikter slik at bedriftene kan sende relevant og engasjerende budskap til dens kunder så markedet kan vinne sammen.

Betongsentrum AS is offering an easier online solution for planning and ordering concrete for your project. Our digital platform makes concrete deliveries more efficient, safer and more environmentally friendly along with giving all project participants a visual overview of the progress and their own responsibilities. This ensures quality in every link, satisfied customers and a better end result.

Migraine is an underdiagnosed and undertreated brain disease. 1 in 7 people worldwide is affected by migraine. Nordic Brain Tech develops a treatment that is home-based and self-administered. The invention has gotten worldwide attention from key opinion leaders within migraine. There is a huge market need, and a willingness to pay for the product from both hospitals and migraine patients.

Transition Elements explores for energy transition metals in Norway, using technology and software to enhance exploration efficiency and reduce risk and cycle times for bringing new deposits to market. We aim to increase the supply of metals essential for the transition to a low carbon economy. With a cumulative team experience of around 60 years across geology, software development and innovation, we will integrate existing technology, new software, and expert knowledge to generate the fastest and most effective exploration system in the business.

iO Data is here to help companies build their digital businesses. Only 33% of companies rate their level of digitalization as advanced today, but 70% expect they will get there by 2020¹. This transformation process will be critical for future success. Our core business is hosting, conversion, QC, and accessibility of Big Data. Bundled with Security Audits, Embedded Development, Destruction, Consultancy, and Innovation.

Elife E-bikesWe design and import components directly from industries (Germany etc.) and handmake e-bikes in Norway. This is the 3 rd year for us, we have our shop in Oslo and started our focus on developing&producing. We have distributors in Norway and Iceland. Our advantage is that all our competitors can be potential partners. In 2018, we have handmade the lightest three-seater "e-bike-car" in the world - iCloud. It allows 2 People to pedal at the same time. It protects you from bad weather & has a 150L trunk. Its battery range is 200km.

Ose Water AS is a Norwegian bottled water and bag-in-box water producer.The water source is Ose which provides high quality natural mineral water. The company aim to be in production for international sale in Q1 2019. Ose Water AS is a producer of natural mineral water from the Ose spring in Bygland municipality, Aust-Agder county in Norway.

GI ALLE MULIGHET TIL Å INVESTERE I VEKSTSELSKAPER GJENNOM AKSJEKJØP. Folkeinvest AS ønsker med webtjenesten folkeinvest.no å demokratisere investering i oppstartsselskaper.Emisjonsprosessen har frem til nå være komplisert både for selskapet og de som vil investere. Derfor har slike investeringer vanligvis kun blitt tilbudt bekjente av selskapet og profesjonelle investorer.Folkefinansiering med lave minstebeløp og en lettfattelig webtjeneste gir alle mulighet til å investere.Å investere i oppstartsselskaper er forbundet med risiko for at investeringen kan gå tapt. Mange selskaper overlever ikke sine fem første år. Men det er også i den fasen at verdistigningen kan bli høy. Vi mener at denne investeringsmuligheten bør være tilgjengelig for alle.Folkeinvest.no har åpne investorlister, diskusjonsforum og krav til dokumentasjon som gjør at aksjekjøpere er godt rustet til å ta investeringsbesluttninger.

Amina Charging is a technology startup on a mission to give our planet a greener future by scaling the transition to electric vehicles (EV). We create environmental sustainability solutions grounded in sound business and global scalability. We work and play with curiosity, creativity and ambition. At Amina, we never compromise on sustainability, scale and sound business. We work with passion and insight, and prize impact and progress over process. We empower your creative autonomy but you will never struggle alone. We work as a team in an open culture that rewards sharing ideas and supporting each other.

An intracellular approach to diagnostics – changing the way diagnostics approach blood tests. Pre Diagnostics is the first diagnostics company to focus on intracellular measurements of disease-specific biomarkers inside the blood cells. We extract disease-relevant information from biomarkers located inside specific blood cells called monocytes to provide actionable results for patients and practitioners.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.